For years, mosquito nets have been one of the most familiar tools in Nigeria’s fight against malaria. Now, Nigeria is beginning to manufacture a new generation of those nets locally, in a development that could change how an important malaria-prevention product is supplied in the country.
Health Textiles Nigeria FZE has commenced operations at a manufacturing facility in the Lagos Free Zone, becoming the first facility in Nigeria to produce dual-active ingredient insecticide-treated mosquito nets, according to the Federal Ministry of Health and Social Welfare.
The factory is owned by Vestergaard SΓ rl and will manufacture PermaNet Dual, a mosquito net designed to address the growing problem of mosquitoes developing resistance to conventional insecticides.
At full production, the facility is expected to manufacture approximately 10 million nets annually and create more than 600 jobs. About 80 employees have already been recruited and are undergoing training in manufacturing, quality control, occupational health and safety, and regulatory compliance.
Why the New Mosquito Nets Matter
The importance of the development lies partly in what makes the nets different.
Traditional insecticide-treated nets rely on insecticides to kill or repel mosquitoes that come into contact with the treated material. But resistance to commonly used insecticides has become an increasing challenge in malaria control.
PermaNet Dual uses two active ingredients with different modes of action. The product has been designed specifically to help address insecticide resistance and was prequalified by the World Health Organization in 2023.
That does not mean the new nets eliminate malaria or make mosquitoes incapable of transmitting the disease. Rather, they represent another tool that malaria-control programmes can use where insecticide resistance is a concern.
Nigeria Carries a Heavy Malaria Burden
The timing is significant because Nigeria remains one of the countries most heavily affected by malaria.
The World Health Organization estimated that malaria caused approximately 282 million cases and 610,000 deaths worldwide in 2024. The African Region accounted for about 95 percent of cases and deaths globally.
Nigeria accounted for about 31.9 percent of malaria deaths in the African Region in 2024, according to figures reported from the WHO’s latest estimates.
These figures explain why malaria prevention remains a major public-health priority in Nigeria.
Insecticide-treated nets are among the established interventions used to reduce exposure to malaria-carrying mosquitoes. WHO identifies them as an important method for preventing mosquito bites and reducing malaria transmission.
A Shift Toward Local Manufacturing
The new factory also represents a change in how Nigeria approaches the supply of essential health products.
Instead of depending entirely on imported mosquito nets, the country now has a domestic facility capable of producing a next-generation product.
The Federal Ministry of Health described the development as part of efforts to strengthen Nigeria’s healthcare value chain through local production, investment and technology transfer.
For Nigeria, domestic manufacturing could potentially shorten supply chains and increase local technical capacity.
However, local production alone does not guarantee that every Nigerian household will have access to a mosquito net. Distribution, affordability, procurement, quality control and effective malaria programmes will still determine how much public-health benefit the new manufacturing capacity produces.
More Than 600 Jobs Expected
The factory is also being presented as an industrial investment rather than solely a health intervention.
At full scale, Health Textiles Nigeria expects to produce around 10 million nets every year and employ more than 600 people.
The company has already recruited about 80 workers.
Those employees are receiving training in areas including manufacturing excellence, product quality, occupational safety and regulatory compliance. The government says this combination of production and skills development is part of its broader effort to strengthen domestic healthcare manufacturing.
The effect could extend beyond direct employment if local suppliers and service providers become involved in the wider production and distribution chain.
The Government’s Healthcare Manufacturing Strategy
The facility follows a 2024 Memorandum of Understanding between Vestergaard and the Presidential Initiative for Unlocking the Healthcare Value Chain.
The initiative is intended to encourage investment and increase Nigeria’s ability to produce essential health products domestically.
Coordinating Minister of Health and Social Welfare Muhammad Ali Pate said the mosquito-net facility demonstrates what can happen when government policy, private investment and technology transfer are combined.
The wider objective is to create more domestic capacity across Nigeria’s healthcare value chain rather than relying heavily on imported products.
What Happens to the Nets Next?
Production has begun, but the first commercial orders are not expected to be fulfilled until the coming months.
That means the immediate significance of the factory is the establishment of production capacity rather than an instant nationwide change in mosquito-net availability.
How widely the new nets are distributed will depend on future procurement and malaria-control programmes.
Quality assurance will also be important. The Health Ministry says domestic production will operate under regulatory oversight and safety standards as the government promotes local manufacturing of strategic health products.
Local Production Does Not Replace Other Malaria Measures
The introduction of dual-active mosquito nets should not be viewed as a replacement for other malaria-control measures.
Malaria prevention involves multiple approaches, including reducing mosquito exposure, diagnosis and treatment, surveillance and other vector-control interventions.
The new nets provide another tool, particularly in settings where mosquitoes have developed resistance to commonly used insecticides.
Their ultimate effect will therefore depend not only on how many nets are produced but also on whether they reach the communities that need them and are used correctly.
A Potential Regional Manufacturing Hub
The Lagos facility could eventually have significance beyond Nigeria.
Health Textiles Nigeria describes the operation as a manufacturing hub for next-generation mosquito nets in West Africa. Its planned capacity of 10 million nets annually gives it the potential to serve a substantial market if production and distribution expand as planned.
For a region carrying a large share of the world’s malaria burden, producing prevention products closer to where they are needed could strengthen supply-chain resilience.
That potential, however, will depend on actual production levels, procurement arrangements and demand from malaria-control programmes in Nigeria and other countries.
The Bigger Test
Nigeria’s new mosquito-net factory represents an important step in domestic healthcare manufacturing, but the real test will come after production begins at scale.
The country now has the capacity to manufacture a next-generation malaria-prevention product locally. The next questions are whether the factory reaches its projected output, whether the nets become widely available, and whether they contribute measurably to malaria prevention.
For a country facing one of the world’s largest malaria burdens, the significance of the development ultimately will not be measured by the opening of a factory alone, but by how effectively the products reach the people who need them.
Community
Comments
Keep discussion respectful and relevant. Comments never affect rewards.
No comments yet. Start a respectful conversation.